<DOC>
	<DOC>NCT02650843</DOC>
	<brief_summary>This project aims to clarify the role non-motor symptoms in the development of Parkinson's disease (PD) and to improve diagnostics at very early stages of PD. The project involves multidimensional measures of disease biomarkers together with brain dopamine transporter (DAT) imaging with [123I]FP-CIT single photon emission computed tomography (SPECT).</brief_summary>
	<brief_title>Non-motor Symptoms and Brain Dopamine Transporter Binding</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>Male or Female Age 18100 years Referred for clinical DAT SPECT in Turku or Helsinki</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Parkinsonism</keyword>
	<keyword>DAT Dopamine transporter</keyword>
	<keyword>SPECT</keyword>
</DOC>